Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Your practitioner will assess your individual needs and advise accordingly
USA 96 , 1523915244 (1999)
WO 00/53148 discloses and claims a "method for the treatment of erectile dysfunction which comprises administering to a human subject in need of such treatment an effective amount of an agonist of the melanocortin receptor in combination with an effective amount of a cyclic-GMP- specific phosphodiesterase inhibitor or an alpha-andrenergic receptor antagonist. MT-II is a disclosed melanocortin receptor agonist and sildenafil is a disclosed PDE-5 inhibitor
Early detection makes treatment much more effective
US$ 27.75
US$ 25.30
US$ 29.78
US$ 23.86
US$ 25.36
US$ 28.32
US$ 29.08
